Lian Group, a Luxembourg-based provider of a healthcare investment platform, acquired Scientis, a Geneva, Switzerland-based cosmeceutical company.
The amount of the deal was not disclosed
This acquisition strengthens and expands Lian’s footprint in the healthcare industry, where it focuses on investing in the build-out of companies with solutions that address evolving needs.
Scientis is a dermatology company dedicated to skin pigmentation with its flagship product Cyspera®, which contains the proprietary Cysteamine Isobionic-Amide Complex™ , a clinically proven pigment corrector. Its formula features antioxidant properties, and positions Cyspera as topical product to harness these benefits for uneven skin tone and discoloration. The company is ready for global market penetration, building on an established presence in Asia and the US.
Led by Fiorenzo Manganiello, Managing Partner, Lian Group is an investment firm building and funding companies while collaborating closely with entrepreneurial leaders. It generates value by investing money and expertise, with a focus on opportunities in healthcare, and digital assets and infrastructure.
FinSMEs
29/08/2024